# Comparing the Sleep Strip OTC™ Accuracy in Screening for Sleep Apnea Syndrome Against the Reference Method, an In-lab Full Night Polysomnographic (PSG)

> **NCT00942669** · PHASE1,PHASE2 · COMPLETED · sponsor: **Scientific Laboratory Products, Ltd.** · enrollment: 80 (actual)

## Conditions studied

- Sleep Apnea Syndrome

## Interventions

- **DEVICE:** SleepStrip OTC(TM)

## Key facts

- **NCT ID:** NCT00942669
- **Lead sponsor:** Scientific Laboratory Products, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-11
- **Final completion:** 2012-02
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2012-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942669, "Comparing the Sleep Strip OTC™ Accuracy in Screening for Sleep Apnea Syndrome Against the Reference Method, an In-lab Full Night Polysomnographic (PSG)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00942669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*